Morgan Stanley Sees Early Benefits from Reform for LifePoint Hospitals

In a report published Monday, Morgan Stanley analyst Andrew Schenker reiterated an Equal-Weight rating on LifePoint Hospitals (NASDAQ: LPNT).

In the report, Morgan Stanley noted, “Early benefits from reform exceeded expectations with a ~26% decline in self-pay admissions. LPNT now expects reform benefit to be at the high end of their guidance range of 4% to 5% of adj. EBITDA. However, underlying utilization trends remained an overhang on performance.”

LifePoint Hospitals closed on Friday at $56.87.